Evidence map›Paper›PMID 31619245›Full record

ArticleRespiratory research2019

Influence of β

Eli F Kelley, Troy J Cross, Eric M Snyder, Craig M McDonald, CINRG Investigators, Eric P Hoffman, Luca Bello

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Respiratory research, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed, 1 pooled it
0.5field-weighted citation impact, top 32% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 1 synthesis or guideline pooled it, 12 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Review
  5. Review
  6. Article
  7. Review
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 2 countries.

Eli F KelleyDepartment of Kinesiology, University of Minnesota, Minneapolis, MN, USA. kelley.eli@mayo.edu.ORCID http://orcid.org/0000-0001-8337-2253
Troy J CrossDepartment of Cardiovascular Diseases, Mayo Clinic, RO_GE_MN_10, 1216 2nd Street SW, Rochester, MN, 55902, USA.
Eric M SnyderDepartment of Kinesiology, University of Minnesota, Minneapolis, MN, USA.
Craig M McDonaldUniversity of California Davis Medical Center, Sacramento, CA, USA.
CINRG Investigators
Eric P HoffmanBinghamton University - SUNY, Binghamton, NY, USA.
Luca BelloDepartment of Neurosciences, University of Padova, Padova, Italy.
University of Minnesota · USBinghamton University · USUniversity of Padua · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Duchenne muscular dystrophy (DMD) is a progressive neuromuscular disease resulting in severe respiratory derangements. As such, DMD patients are at a high risk of nocturnal hypoventilation, thereby requiring nocturnal ventilation (NV). To this end, NV is an important clinical milestone in the management of DMD. Emerging evidence suggests that ß

Indexed as

GenotypeRespiration, ArtificialAdolescentAdultChildChild, PreschoolDatabases, GeneticHumansHypoventilationMuscular Dystrophy, DuchennePolymorphism, GeneticReceptors, Adrenergic, beta-2Young AdultADRB2 protein, humanReceptors, Adrenergic, beta-2beta2-adrenergic receptorDuchenne muscular dystrophyGenotypeNocturnal ventilationRespiratoryRisk

Identifiers

PMID31619245
PMCPMC6796481
OpenAlexW2980937144

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.